National Medical Care Company SJSC 4005.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

108.10

—

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 1.60bn

FY2016FY2025

Net income

SAR 318.0m

FY2016FY2025

Free cash flow

SAR 22.0m

FY2016FY2025

Shareholders' equity

SAR 1.85bn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	SAR 1.60bn	SAR 1.29bn	SAR 1.08bn	SAR 917.9m	SAR 845.4m	SAR 809.0m	SAR 708.4m	SAR 763.8m	SAR 855.1m	SAR 900.7m
Gross profit	SAR 589.0m	SAR 454.1m	SAR 369.6m	SAR 289.7m	SAR 246.5m	SAR 223.9m	SAR 165.7m	SAR 166.5m	SAR 195.4m	SAR 204.6m
Operating income	SAR 373.3m	SAR 296.9m	SAR 246.7m	SAR 197.4m	SAR 155.3m	SAR 114.1m	SAR 104.8m	SAR 88.4m	SAR 103.8m	SAR 78.7m
Net income	SAR 318.0m	SAR 298.2m	SAR 240.9m	SAR 170.1m	SAR 136.4m	SAR 97.3m	SAR 80.1m	SAR 62.2m	SAR 85.3m	SAR 49.3m
Diluted earnings per share	7.18	6.67	5.37	3.79	3.04	2.17	1.79	1.39	1.90	1.09

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	SAR 2.77bn	SAR 2.50bn	SAR 2.21bn	SAR 1.71bn	SAR 1.56bn	SAR 1.43bn	SAR 1.36bn	SAR 1.39bn	SAR 1.43bn	SAR 1.41bn
Cash and short-term investments	SAR 530.6m	SAR 566.8m	SAR 693.7m	SAR 329.2m	SAR 375.0m	SAR 372.7m	SAR 379.7m	SAR 344.6m	SAR 117.4m	SAR 904.0m
Total liabilities	SAR 921.7m	SAR 872.7m	SAR 760.9m	SAR 449.1m	SAR 435.1m	SAR 395.7m	SAR 323.4m	SAR 395.5m	SAR 439.5m	SAR 1.41bn
Debt	SAR 364.2m	SAR 487.7m	SAR 330.2m	SAR 83.2m	SAR 89.1m	SAR 95.1m	SAR 101.0m	SAR 170.6m	SAR 194.7m	SAR 218.8m
Shareholders' equity	SAR 1.85bn	SAR 1.63bn	SAR 1.45bn	SAR 1.26bn	SAR 1.12bn	SAR 1.04bn	SAR 1.03bn	SAR 996.9m	SAR 985.6m	SAR 911.2m
Shares outstanding	44m	45m	45m	45m	45m	45m	45m	45m	45m	45m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	SAR 153.0m	SAR 244.7m	SAR 466.7m	SAR 216.9m	SAR 93.8m	SAR 106.7m	SAR 161.8m	SAR 317.8m	SAR 110.7m	SAR 105.4m
Capital spending	−SAR 131.0m	−SAR 251.2m	−SAR 54.6m	−SAR 211.8m	−SAR 40.9m	−SAR 18.2m	−SAR 10.2m	−SAR 19.2m	−SAR 73.6m	−SAR 58.4m
Free cash flow	SAR 22.0m	−SAR 6.6m	SAR 412.2m	SAR 5.0m	SAR 52.9m	SAR 88.5m	SAR 151.6m	SAR 298.6m	SAR 37.1m	SAR 47.0m
Dividends paid	−SAR 89.4m	−SAR 89.7m	−SAR 44.9m	−SAR 44.9m	−SAR 44.9m	−SAR 89.7m	−SAR 44.9m	−SAR 44.9m	−SAR 44.9m	−SAR 33.6m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	SAR 456.4m	SAR 388.0m	SAR 404.4m	SAR 412.4m	SAR 397.9m	SAR 385.3m	SAR 372.5m	SAR 325.8m
Gross profit	SAR 197.1m	SAR 151.2m	SAR 147.1m	SAR 151.5m	SAR 147.5m	SAR 143.0m	SAR 124.2m	SAR 111.5m
Operating income	SAR 106.8m	SAR 63.0m	SAR 81.5m	SAR 90.4m	SAR 85.0m	SAR 97.2m	SAR 88.6m	SAR 70.9m
Net income	SAR 94.0m	SAR 52.5m	SAR 71.0m	SAR 82.2m	SAR 79.9m	SAR 85.4m	SAR 87.2m	SAR 60.2m
Diluted earnings per share	2.10	1.17	1.60	1.86	1.81	1.93	1.95	1.35
Cash from operations	−SAR 91.0m	−SAR 28.0m	SAR 125.0m	−SAR 52.0m	−SAR 77.0m	SAR 157.0m	SAR 299.0m	−SAR 37.0m
Capital spending	−SAR 104.0m	−SAR 52.0m	−SAR 62.0m	−SAR 23.0m	−SAR 25.0m	−SAR 22.0m	−SAR 32.0m	−SAR 26.0m
Free cash flow	−SAR 195.0m	−SAR 80.0m	SAR 63.0m	−SAR 75.0m	−SAR 102.0m	SAR 135.0m	SAR 267.0m	−SAR 63.0m
Total assets	SAR 3.03bn	SAR 3.02bn	SAR 2.77bn	SAR 2.60bn	SAR 2.54bn	SAR 2.58bn	SAR 2.50bn	SAR 2.23bn
Cash and short-term investments	—	—	SAR 530.6m	SAR 373.7m	SAR 477.2m	SAR 677.2m	SAR 566.8m	SAR 279.1m
Debt	SAR 461.1m	SAR 408.7m	SAR 364.2m	SAR 276.8m	SAR 295.7m	SAR 310.4m	SAR 319.1m	SAR 273.0m
Shareholders' equity	SAR 1.86bn	SAR 1.90bn	SAR 1.85bn	SAR 1.79bn	SAR 1.71bn	SAR 1.71bn	SAR 1.63bn	SAR 1.54bn

Financial ratios

Data as of 10 Oct 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Gross margin	36.8%	35.1%	34.2%	31.6%	29.2%	27.7%	—	—
Operating margin	23.3%	24.5%	24.8%	21.6%	19.4%	14.3%	—	—
Net margin	19.9%	23.0%	22.3%	18.5%	16.1%	12.0%	—	—
Return on equity	17.2%	18.3%	16.6%	13.5%	12.1%	9.4%	—	—
Return on assets	11.5%	11.9%	10.9%	9.9%	8.7%	6.8%	—	—
Free cash flow yield	5.9%	10.2%	10.7%	8.8%	2.8%	2.6%	—	—
Revenue growth	23.7%	19.6%	17.8%	8.6%	4.5%	14.2%	—	—
Earnings growth	6.7%	23.8%	41.7%	24.7%	40.2%	21.5%	—	—
Current ratio	4.30x	3.53x	3.68x	3.69x	4.20x	4.36x	—	—
Debt to equity	0.20x	0.20x	0.19x	0.07x	0.08x	0.09x	—	—
Equity ratio	66.7%	65.1%	65.6%	73.8%	72.1%	72.4%	—	—
Interest coverage	13.84x	13.91x	76.70x	—	—	552.71x	47.23x	30.33x
Buybacks as a share of market value	0.9%	0.4%	0.0%	0.0%	0.0%	0.0%	—	—

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	20.3%	14.6%	6.2%
Operating income	23.7%	26.8%	11.2%
Net income	23.2%	26.7%	9.3%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	36.0%	34.8%	33.2%	29.3%
Operating margin	23.2%	22.8%	21.1%	17.7%
Net margin	21.3%	21.0%	19.3%	15.7%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	19.9	25.0	32.5	19.5	20.6	24.6	27.2	36.3	23.0	60.1
Price to sales	4.0	5.8	7.2	3.6	3.3	3.0	3.1	3.0	2.3	3.3

Dividends and splits

Per share, in the currency the company pays

Paid for 8 years. Last went ex-dividend on 5 May 2026.

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Paid in the year	3.00	2.00	2.00	1.00	1.00	1.00	2.00	1.00

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

National Medical Care Company SJSC 4005.SR · SAR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology